老年食管鳞状细胞癌患者生存的临床预测因素

IF 0.3 Q4 GASTROENTEROLOGY & HEPATOLOGY
Kuan-Ming Lai, Chien-Yu Tsai, Sheng-Lei Yan
{"title":"老年食管鳞状细胞癌患者生存的临床预测因素","authors":"Kuan-Ming Lai,&nbsp;Chien-Yu Tsai,&nbsp;Sheng-Lei Yan","doi":"10.1002/aid2.13423","DOIUrl":null,"url":null,"abstract":"<p>Prognostic factors for poor survival have been proposed in esophageal squamous cell carcinoma (SCC) patients receiving concurrent chemoradiotherapy (CRT). However, little is known about the association of pretreatment platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte (NLR) levels and treatment outcomes in elderly SCC patients. We conducted a retrospective study of elderly patients with esophageal SCC to find out clinical factors affecting survival. From January 2008 to December 2017, a total of 106 esophageal SCC patients with age more than 65 years old were enrolled. All included patients had undergone either concurrent CRT or radiotherapy (RT). Complete blood count, differential count, NLR, and PLR were obtained before treatment. Univariate and multivariate Cox regression analyses were used to assess the association between survival and patient, disease, and treatment characteristics. Seventy-five patients received CRT, while the remaining 31 patients were treated with RT alone. Multivariate analysis showed that CRT (<i>p</i> = .03, hazard ratio [HR] [95% confidence interval, CI] = 0.589 [0.365–0.95]), female (<i>p</i> = .011, HR [95% CI] = 0.216 [0.066–0.703]), ECOG performance status 0–I (<i>p</i> &lt; .001, HR [95% CI] = 3.514 [2.049–6.026]), hemoglobin (Hb) ≥12 g/dL (<i>p</i> &lt; .01, HR [95% CI] = 0.57 [0.37–0.878]) were independent factors for predicting better overall survival (OS). Independent factors for predicting better disease-specific survival (DSS) included ECOG performance status 0–I (<i>p</i> &lt; .001, HR [95% CI] = 3.147 [1.802–5.497]), Clinical staging I–II (<i>p</i> = .023, HR [95% CI] = 2.124 [1.112–4.060]) and, NLR &lt;5.3 (<i>p</i> = .029, HR [95% CI] = 1.706 [1.058–2.752]). Our study showed that CRT, gender, ECOG performance status, Hb level, were independent predictors of OS; whereas ECOG performance status, clinical staging and NLR were independent predictors of DSS. Pretreatment NLR &gt;5.3 is an independent poor prognostic factor for DSS of elderly esophageal SCC patients. Because our study is a retrospective analysis, further prospective studies are needed to validify the findings in our study.</p>","PeriodicalId":7278,"journal":{"name":"Advances in Digestive Medicine","volume":"12 1","pages":""},"PeriodicalIF":0.3000,"publicationDate":"2025-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/aid2.13423","citationCount":"0","resultStr":"{\"title\":\"Clinical predictors of survival for elderly patients with esophageal squamous cell carcinoma\",\"authors\":\"Kuan-Ming Lai,&nbsp;Chien-Yu Tsai,&nbsp;Sheng-Lei Yan\",\"doi\":\"10.1002/aid2.13423\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Prognostic factors for poor survival have been proposed in esophageal squamous cell carcinoma (SCC) patients receiving concurrent chemoradiotherapy (CRT). However, little is known about the association of pretreatment platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte (NLR) levels and treatment outcomes in elderly SCC patients. We conducted a retrospective study of elderly patients with esophageal SCC to find out clinical factors affecting survival. From January 2008 to December 2017, a total of 106 esophageal SCC patients with age more than 65 years old were enrolled. All included patients had undergone either concurrent CRT or radiotherapy (RT). Complete blood count, differential count, NLR, and PLR were obtained before treatment. Univariate and multivariate Cox regression analyses were used to assess the association between survival and patient, disease, and treatment characteristics. Seventy-five patients received CRT, while the remaining 31 patients were treated with RT alone. Multivariate analysis showed that CRT (<i>p</i> = .03, hazard ratio [HR] [95% confidence interval, CI] = 0.589 [0.365–0.95]), female (<i>p</i> = .011, HR [95% CI] = 0.216 [0.066–0.703]), ECOG performance status 0–I (<i>p</i> &lt; .001, HR [95% CI] = 3.514 [2.049–6.026]), hemoglobin (Hb) ≥12 g/dL (<i>p</i> &lt; .01, HR [95% CI] = 0.57 [0.37–0.878]) were independent factors for predicting better overall survival (OS). Independent factors for predicting better disease-specific survival (DSS) included ECOG performance status 0–I (<i>p</i> &lt; .001, HR [95% CI] = 3.147 [1.802–5.497]), Clinical staging I–II (<i>p</i> = .023, HR [95% CI] = 2.124 [1.112–4.060]) and, NLR &lt;5.3 (<i>p</i> = .029, HR [95% CI] = 1.706 [1.058–2.752]). Our study showed that CRT, gender, ECOG performance status, Hb level, were independent predictors of OS; whereas ECOG performance status, clinical staging and NLR were independent predictors of DSS. Pretreatment NLR &gt;5.3 is an independent poor prognostic factor for DSS of elderly esophageal SCC patients. Because our study is a retrospective analysis, further prospective studies are needed to validify the findings in our study.</p>\",\"PeriodicalId\":7278,\"journal\":{\"name\":\"Advances in Digestive Medicine\",\"volume\":\"12 1\",\"pages\":\"\"},\"PeriodicalIF\":0.3000,\"publicationDate\":\"2025-03-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/aid2.13423\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Digestive Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/aid2.13423\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Digestive Medicine","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/aid2.13423","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

在接受同步放化疗(CRT)的食管鳞状细胞癌(SCC)患者中,预后因素已被提出。然而,对于老年SCC患者的预处理血小板与淋巴细胞比率(PLR)和中性粒细胞与淋巴细胞(NLR)水平与治疗结果的关系知之甚少。我们对老年食管鳞状细胞癌患者进行回顾性研究,以找出影响生存的临床因素。2008年1月至2017年12月,共纳入106例年龄大于65岁的食管SCC患者。所有纳入的患者均接受了同步CRT或放疗(RT)。治疗前检测全血细胞计数、差异计数、NLR、PLR。采用单因素和多因素Cox回归分析来评估生存率与患者、疾病和治疗特征之间的关系。75例患者接受CRT治疗,其余31例患者单独接受RT治疗。多因素分析显示,CRT (p =。03,风险比[HR][95%可信区间,CI] = 0.589[0.365-0.95]),女性(p =。011, HR [95% CI] = 0.216 [0.066-0.703]), ECOG表现状态0-I (p <;001年,人力资源(95%置信区间)= 3.514(2.049 - -6.026)),血红蛋白(Hb)≥12 g / dL (p & lt;。0.01, HR [95% CI] = 0.57[0.37-0.878])是预测更好的总生存期(OS)的独立因素。预测更好的疾病特异性生存(DSS)的独立因素包括ECOG性能状态0-I (p <)。001年,人力资源(95%置信区间)= 3.147(1.802 - -5.497)),临床分期i ii (p =。023年,人力资源(95%置信区间)= 2.124 (1.112 - -4.060)),NLR & lt; 5.3 (p =。029, hr [95% ci] = 1.706[1.058-2.752])。我们的研究表明,CRT、性别、ECOG表现状态、Hb水平是OS的独立预测因素;而ECOG表现状态、临床分期和NLR是DSS的独立预测因子。预处理NLR >;5.3是老年食管鳞状细胞癌患者DSS的独立不良预后因素。由于我们的研究是回顾性分析,需要进一步的前瞻性研究来验证我们的研究结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Clinical predictors of survival for elderly patients with esophageal squamous cell carcinoma

Clinical predictors of survival for elderly patients with esophageal squamous cell carcinoma

Prognostic factors for poor survival have been proposed in esophageal squamous cell carcinoma (SCC) patients receiving concurrent chemoradiotherapy (CRT). However, little is known about the association of pretreatment platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte (NLR) levels and treatment outcomes in elderly SCC patients. We conducted a retrospective study of elderly patients with esophageal SCC to find out clinical factors affecting survival. From January 2008 to December 2017, a total of 106 esophageal SCC patients with age more than 65 years old were enrolled. All included patients had undergone either concurrent CRT or radiotherapy (RT). Complete blood count, differential count, NLR, and PLR were obtained before treatment. Univariate and multivariate Cox regression analyses were used to assess the association between survival and patient, disease, and treatment characteristics. Seventy-five patients received CRT, while the remaining 31 patients were treated with RT alone. Multivariate analysis showed that CRT (p = .03, hazard ratio [HR] [95% confidence interval, CI] = 0.589 [0.365–0.95]), female (p = .011, HR [95% CI] = 0.216 [0.066–0.703]), ECOG performance status 0–I (p < .001, HR [95% CI] = 3.514 [2.049–6.026]), hemoglobin (Hb) ≥12 g/dL (p < .01, HR [95% CI] = 0.57 [0.37–0.878]) were independent factors for predicting better overall survival (OS). Independent factors for predicting better disease-specific survival (DSS) included ECOG performance status 0–I (p < .001, HR [95% CI] = 3.147 [1.802–5.497]), Clinical staging I–II (p = .023, HR [95% CI] = 2.124 [1.112–4.060]) and, NLR <5.3 (p = .029, HR [95% CI] = 1.706 [1.058–2.752]). Our study showed that CRT, gender, ECOG performance status, Hb level, were independent predictors of OS; whereas ECOG performance status, clinical staging and NLR were independent predictors of DSS. Pretreatment NLR >5.3 is an independent poor prognostic factor for DSS of elderly esophageal SCC patients. Because our study is a retrospective analysis, further prospective studies are needed to validify the findings in our study.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in Digestive Medicine
Advances in Digestive Medicine GASTROENTEROLOGY & HEPATOLOGY-
自引率
33.30%
发文量
42
期刊介绍: Advances in Digestive Medicine is the official peer-reviewed journal of GEST, DEST and TASL. Missions of AIDM are to enhance the quality of patient care, to promote researches in gastroenterology, endoscopy and hepatology related fields, and to develop platforms for digestive science. Specific areas of interest are included, but not limited to: • Acid-related disease • Small intestinal disease • Digestive cancer • Diagnostic & therapeutic endoscopy • Enteral nutrition • Innovation in endoscopic technology • Functional GI • Hepatitis • GI images • Liver cirrhosis • Gut hormone • NASH • Helicobacter pylori • Cancer screening • IBD • Laparoscopic surgery • Infectious disease of digestive tract • Genetics and metabolic disorder • Microbiota • Regenerative medicine • Pancreaticobiliary disease • Guideline & consensus.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信